SUNESIS PHARMACEUTICALS INC Business Finance Contracts & Agreements
67 Contracts & Agreements
- Assignment Agreements (3 contracts)
- Investor Rights Agreements (2)
- Loan Agreements (11)
- Note Agreements (2)
- Participation Agreements (1)
- Purchase Agreements (1)
- Registration Rights Agreements (2)
- Release Agreements (2)
- Security Agreements (1)
- Stock Agreements (14)
- Underwriting Agreements (13)
- Warrant Agreements (15)
- First Amendment to Loan and Security Agreement between the Registrant. and Silicon Valley Bank, dated as of August 26, 2022 (Filed With SEC on November 10, 2022)
- 2022 Employee Stock Purchase Plan (Filed With SEC on June 8, 2022)
- Loan and Security Agreement, dated November 4, 2021, by and among Viracta Therapeutics, Inc., Viracta Subsidiary, Inc., Silicon Valley Bank and Oxford Finance LLC (Filed With SEC on November 10, 2021)
- First Amendment to Loan and Security Agreement between Viracta Subsidiary, Inc. and Silicon Valley Bank, dated as of May 27, 2021 (Filed With SEC on May 28, 2021)
- Royalty Purchase Agreement by and between the Registrant and XOMA (US) LLC, dated March 22, 2021 (Filed With SEC on May 13, 2021)
- Description of Capital Stock (Filed With SEC on February 24, 2021)
- Underwriting Agreement relating to the Offering, dated July 29, 2020 (Filed With SEC on July 31, 2020)
- Description of Capital Stock (Filed With SEC on May 7, 2020)
- Underwriting Agreement relating to the Common Stock Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)
- Underwriting Agreement relating to the Series F Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)
- Form of Specimen Series F Preferred Stock Certificate (Filed With SEC on July 12, 2019)
- Term Loan Agreement, dated April 26, 2019, by and between Sunesis Pharmaceuticals, Inc. and Silicon Valley Bank (Filed With SEC on April 29, 2019)
- Underwriting Agreement relating to the Common Stock Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)
- Underwriting Agreement relating to the Series E Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)
- Form of Specimen Series E Preferred Stock Certificate (Filed With SEC on January 22, 2019)
- Registration Rights Agreement, dated as of June 25, 2018, by and between Sunesis Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 25, 2018)
- Common Stock Purchase Agreement, dated as of June 25, 2018, by and between Sunesis Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 25, 2018)
- Second Amendment to Loan and Security Agreement (Filed With SEC on November 2, 2017)
- Underwriting Agreement relating to the Common Stock Offering, dated October 25, 2017 (Filed With SEC on October 26, 2017)
- Underwriting Agreement relating to the Series D Offering, dated October 25, 2017 (Filed With SEC on October 26, 2017)
- Form of Specimen Series D Preferred Stock Certificate (Filed With SEC on October 26, 2017)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 26, 2017)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 30, 2017)
- 4,935,500 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2016)
- 1,558 Shares SUNESISPHARMACEUTICALS, INC. Series C Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on May 9, 2016)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 9, 2016)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 9, 2016)
- 9,561,905 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)
- 20,200 Shares SUNESISPHARMACEUTICALS, INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on December 16, 2015)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 2, 2015)
- 4,650,000 Shares Series A Warrants to Purchase 4,650,000 Shares Series B Warrants to Purchase 4,650,000 Shares SUNESIS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 27, 2014)
- COMMON STOCK PURCHASE WARRANT SERIES A CUSIP 867328114 SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2014)
- COMMON STOCK PURCHASE WARRANT SERIES B CUSIP 867328122 SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2014)
- WARRANT AGENCY AGREEMENT (Filed With SEC on February 27, 2014)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 12, 2013)
- REVENUE PARTICIPATION AGREEMENT BY AND BETWEEN SUNESIS PHARMACEUTICALS,INC. AND RPI FINANCE TRUST DATED AS OF MARCH 29, 2012 (Filed With SEC on May 15, 2012)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2012)
- Exhibit A Form of Warrant (Filed With SEC on May 15, 2012)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on October 19, 2011)
